GlassScriptPhysician profile
Nicole M Walton
NPI 1871992057
$13,889.09
in general payments reported to CMS, 2019-2025
33 companies · $6,555 in 2025
The $6,555 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,310 · 2022: $1,659 · 2023: $1,876 · 2024: $2,489 · 2025: $6,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,346 · Travel and Lodging: $2,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,346.15 |
| Travel and Lodging | $2,574.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $3,747.84 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $2,507.26 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Abbott Laboratories | $1,452.82 | 2021-2025 | Proclaim, Eterna |
| Nalu Medical, INC. | $1,306.12 | 2021-2025 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $1,260.88 | 2021-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $980.67 | 2021-2024 | Senza |
| Abbvie INC. | $515.77 | 2021-2025 | |
| Medtronic, INC. | $360.15 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $320.96 | 2022-2025 | Sprint Pns System |
| Grt US Holding, INC. | $204.92 | 2021-2022 | |
| Tersera Therapeutics LLC | $201.82 | 2022-2025 | Prialt |
| Collegium Pharmaceutical, INC. | $159.07 | 2023-2025 | Belbuca, Xtampza |
| Mml US, INC. | $119.93 | 2022 | |
| Averitas Pharma INC. | $84.31 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $71.78 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $67.35 | 2021-2022 | |
| Ibsa Pharma INC. | $66.82 | 2023-2025 | Tirosint, Licart, Tirosint |
| Protega Pharmaceutials INC | $66.44 | 2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $58.95 | 2024-2025 | |
| Curonix LLC | $40.43 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $36.76 | 2023-2025 | Hym/Hyn, Hymovis, Triluron |
| Pfizer INC. | $31.03 | 2021-2025 | |
| Electronic Waveform Lab, INC. | $25.85 | 2021-2025 | |
| Biotronik Nro, INC. | $24.80 | 2024 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $24.21 | 2022 | |
| Baudax Bio INC. | $23.19 | 2021 | |
| Painteq LLC | $22.59 | 2023 | Painteq |
| Tonix Medicines, INC. | $20.07 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.11 | 2024 | |
| Impel Pharmaceuticals INC. | $17.69 | 2022 | |
| Forte Bio-Pharma LLC | $17.05 | 2024 | Prolate, Nalocet |
| Allergan, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.